Skip to content

Premedication Dyclonine Improves Visibility During Bowel Cleansing for Colonoscopy

Premedication Dyclonine Improves Visibility During Bowel Cleansing for Colonoscopy

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03352700
Enrollment
580
Registered
2017-11-24
Start date
2017-12-01
Completion date
2018-02-01
Last updated
2017-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel Preparation Scale, the Amount of Air Bubble, Adenoma Detection Rate

Brief summary

In this randomized controlled study, consecutive outpatients scheduled for elective colonoscopy were randomized into two groups. Group A patients (n = 300) used only 3L PEG before colonoscopy. Patients in group B (n = 300) were additionally advised to Dyclonine Hydrochloride Mucilage plus 3L PEG, The overall quality of colonoscopy cleaning was evaluated using the Boston Bowel Preparation Scale by a single endoscopist who was blinded to the intervention. Visibility was blindly assessed for the amount of air bubbles and adenoma detection rate (ADR). Difficulty of procedure, and adverse events were also evaluated.

Interventions

DRUG3L PEG

Group A patients (n = 300) used only 3L PEG before colonoscopy.

DRUG3L PEG+Dyclonine Hydrochloride Mucilage

Patients in group B (n = 300) were additionally advised to Dyclonine Hydrochloride Mucilage plus 3 L PEG

Sponsors

Changhai Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patients are between 18-75 years old 2. undergoing colonoscopy for diagnostic investigation, colorectal cancer screening or follow-up

Exclusion criteria

1. suspected gastrointestinal obstruction or perforation 2. severe acute inflammatory bowel disease 3. toxic megacolon 4. ileus or gastric retention, ileostomy, 5. hypersensitivity to any of the ingredients 6. pregnancy and lactation and/or at a risk of becoming pregnant

Design outcomes

Primary

MeasureTime frameDescription
the amount of air bubbles2 daysThe amount of intraluminal air bubbles was classified into four grades as shown below: Grade 0 = No or minimal scattered bubbles; Grade 1 = Bubbles covering at least half the luminal diameter; Grade 2 = Bubbles covering the circumference of the lumen; Grade 3 = Bubbles filling the entire lumen. Bubbles filling the entire lumen.

Secondary

MeasureTime frameDescription
adenoma detection rate2 daysThe secondary end point of the study included adenoma detection rate
mean total adenomas detected beyond first2 daysIt was a new metric called ADR-Plus, the mean number of incremental adenomas after the fist.

Countries

China

Contacts

Primary ContactZhaosheng Li, MD
zhaoshenlismmu@gmail.com+86-21-31161335
Backup ContactYu Bai
baiyu1998@hotmail.com+86-13564665324

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026